Fig. 2From: Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trialOGIRT after MET and PIOMET therapyBack to article page